Hiroshi Ureshino

Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 39

Top Topics

Tyrosine Kinase

Multiple Myeloma

Chronic Myeloid Leukemia

Top Venues

International journal of hematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuta Yamamoto, Tatsuro Watanabe, Hiroshi Ureshino, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Kazuharu Kamachi, Kazunori Kawasoe, Keisuke Kidoguchi, Satoshi Yamashita, Naoko Hattori, Toshikazu Ushijima, Shinya Kimura
DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis. Leukemia (2024)
Yuta Yamamoto, Tatsuro Watanabe, Hiroshi Ureshino, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Kazuharu Kamachi, Kazunori Kawasoe, Keisuke Kidoguchi, Satoshi Yamashita, Naoko Hattori, Toshikazu Ushijima, Shinya Kimura
DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis. Leukemia 38 (7) (2024)
Yuta Yamamoto, Tatsuro Watanabe, Hiroshi Ureshino, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Kazuharu Kamachi, Kazunori Kawasoe, Keisuke Kidoguchi, Satoshi Yamashita, Naoko Hattori, Toshikazu Ushijima, Shinya Kimura
DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis. Leukemia 38 (7) (2024)
Hiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi, Takaaki Ono, Noriyoshi Iriyama, Eiichi Ohtsuka, Emiko Sakaida, Shinya Kimura
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment. Clinics and practice 14 (4) (2024)
Hiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi, Takaaki Ono, Noriyoshi Iriyama, Eiichi Ohtsuka, Emiko Sakaida, Shinya Kimura
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment. Clinics and practice 14 (4) (2024)
Kazunori Kawasoe, Tatsuro Watanabe, Nao Yoshida-Sakai, Yuta Yamamoto, Yuki Kurahashi, Keisuke Kidoguchi, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Fukuda-Kurahashi, Shinya Kimura
A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation. Cancers 15 (20) (2023)
Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe, Nao Yoshida-Sakai, Yuki Fukuda-Kurahashi, Kazunori Kawazoe, Toshimi Hoshiko, Yuta Yamamoto, Yuki Kurahashi, Shinya Kimura
Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia. Cancer research communications 3 (2) (2023)
Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe, Nao Yoshida-Sakai, Yuki Fukuda-Kurahashi, Kazunori Kawazoe, Toshimi Hoshiko, Yuta Yamamoto, Yuki Kurahashi, Shinya Kimura
Combination of a New Oral Demethylating Agent, OR2100, and Venetoclax for Treatment of Acute Myeloid Leukemia. Cancer research communications 3 (2) (2023)
Hiromi Nishi, Susumu Horikoshi, Kouji Ohta, Tetsumi Yoshida, Noriyasu Fukushima, Kyoko Oshita, Syuichi Munenaga, Taro Edahiro, Hiroshi Ureshino, Hideo Shigeishi, Yukio Yoshioka, Masaru Konishi, Noriaki Ide, Yuma Ogawa, Rikou Marukawa, Tomoaki Shintani, Natumi Ino, Mikihito Kajiya, Naoya Kakimoto, Hiroki Ohge, Tatsuo Ichinohe, Hiroyuki Kawaguchi
Efficacy of Low-Level Laser Therapy for Oral Mucositis in Hematologic Patients Undergoing Transplantation: A Single-Arm Prospective Study. Journal of personalized medicine 13 (11) (2023)
Ayano Sugihara, Hiroo Katsuya, Hiroshi Ureshino, Shinichi Kido, Shinya Kimura
Alveolar rhabdomyosarcoma with massive bone marrow infiltration and disseminated intravascular coagulation mimicking acute leukemia. EJHaem 3 (3) (2022)
Hiroshi Ureshino, Kazuharu Kamachi, Haruhiko Sano, Sho Okamoto, Hidekazu Itamura, Mariko Yoshimura, Hiroo Katsuya, Toshihiko Ando, Shinya Kimura
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Naho Kurisu, Tomona Hiyama, Yosuke Harada, Noriyasu Fukushima, Narutaka Katsuya, Hiroshi Ureshino, Tatsuo Ichinohe, Yoshiaki Kiuchi
Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders. Ocular immunology and inflammation (2022)
Taro Edahiro, Hiroshi Ureshino, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe
Successful combination treatment with azacitidine and venetoclax as a bridging therapy for third allogenic stem cell transplantation in a patient with 11q23/MLL-rearranged complex karyotype acute myeloid leukemia. EJHaem 4 (1) (2022)
Taro Edahiro, Hiroshi Ureshino, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe
Successful combination treatment with azacitidine and venetoclax as a bridging therapy for third allogenic stem cell transplantation in a patient with 11q23/MLL-rearranged complex karyotype acute myeloid leukemia. EJHaem 4 (1) (2022)
Hiroshi Ureshino, Kazuharu Kamachi, Takero Shindo, Shinya Kimura
Favorable HLA Polymorphisms are Associated with Lower Molecular Relapse after Tyrosine Kinase Discontinuation in Patients with Chronic Myeloid Leukemia. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 38 (4) (2022)
Yuki Kurahashi, Tatsuro Watanabe, Yuta Yamamoto, Hiroshi Ureshino, Kazuharu Kamachi, Nao Yoshida-Sakai, Yuki Fukuda-Kurahashi, Satoshi Yamashita, Naoko Hattori, Hideaki Nakamura, Atsushi Kawaguchi, Toshikazu Ushijima, Eisaburo Sueoka, Shinya Kimura
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL. Blood advances (2022)
Taro Edahiro, Hiroshi Ureshino, Ren Chishaki, Keita Fujino, Tatsuji Mino, Tetsumi Yoshida, Noriyasu Fukushima, Tatsuo Ichinohe
Successful combination treatment with azacitidine and venetoclax for a patient with acute myeloid leukemia undergoing hemodialysis. Leukemia & lymphoma (2022)
Hiroshi Ureshino
Treatment-free remission and immunity in chronic myeloid leukemia. International journal of hematology 113 (5) (2021)
Keisuke Kidoguchi, Hiroshi Ureshino, Haruna Kizuka-Sano, Kyosuke Yamaguchi, Hiroo Katsuya, Yasushi Kubota, Toshihiko Ando, Masatomo Miura, Naoto Takahashi, Shinya Kimura
Efficacy and safety of ponatinib for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case series from a single institute. International journal of hematology 114 (2) (2021)
Hiroshi Ureshino, Kazuharu Kamachi, Atsujiro Nishioka, Sho Okamoto, Hiroo Katsuya, Mariko Yoshimura, Yasushi Kubota, Toshihiko Ando, Shinya Kimura
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experience. Hematological oncology 39 (4) (2021)
Hiroshi Ureshino, Yuki Kurahashi, Tatsuro Watanabe, Satoshi Yamashita, Kazuharu Kamachi, Yuta Yamamoto, Yuki Fukuda-Kurahashi, Nao Yoshida-Sakai, Naoko Hattori, Yoshihiro Hayashi, Atsushi Kawaguchi, Kaoru Tohyama, Seiji Okada, Hironori Harada, Toshikazu Ushijima, Shinya Kimura
Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects. Molecular cancer therapeutics 20 (8) (2021)
Mai Fujita, Hiroshi Ureshino, Shinya Kimura
Helicobacter cinaedi bacteremia in a patient with primary central nervous system lymphoma. EJHaem 2 (4) (2021)
Hiroshi Ureshino, Koichi Ohshima, Masaharu Miyahara
Multiple myeloma with G-CSF production mimicking chronic neutrophilic leukemia. EJHaem 2 (2) (2021)
Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, Shinya Kimura
HLA Polymorphisms Are Associated with Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Molecular cancer therapeutics 20 (1) (2020)
Sho Okamoto, Hiroshi Ureshino, Atsushi Kawaguchi, Motoaki Miyazono, Yuji Ikeda, Shinya Kimura
Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors. International journal of hematology 112 (1) (2020)
Takero Shindo, Hiroshi Ureshino, Hiroto Kojima, Hidenori Tanaka, Shinya Kimura
Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia. Immunological medicine 44 (2) (2020)
Hiroshi Ureshino, Kazuharu Kamachi
Vascular events may predict the prognosis of patients with chronic myeloid leukemia. International journal of hematology 112 (2) (2020)
Hiroshi Ureshino, Shuichi Koarada, Kazuharu Kamachi, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Toshihiko Ando, Tatsuo Ichinohe, Tomohiro Morio, Shinya Kimura
Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy. International journal of hematology 111 (6) (2020)
Sho Okamoto, Hiroshi Ureshino, Shinya Kimura
J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors. International journal of hematology 112 (3) (2020)
Sho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, Kana Kusaba, Haruna Kizuka-Sano, Haruhiko Sano, Atsujiro Nishioka, Kyosuke Yamaguchi, Kazuharu Kamachi, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Atsushi Kawaguchi, Eisaburo Sueoka, Shinya Kimura
Clinical impact of the CONUT score in patients with multiple myeloma. Annals of hematology 99 (1) (2019)
Keisuke Narita, Hiroshi Ureshino, Shigemasa Hashimoto
Sustained ventricular tachycardia caused by subacute thyroiditis. Internal medicine journal 48 (9) (2019)
Takaomi Kobayashi, Hiroshi Ureshino, Kensuke Hotta, Ko Ikuta
Timing of surgical interventions for upper cervical epidural abscess: a case report and review of the literature. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 29 (6) (2019)
Hiroshi Ureshino, Takero Shindo, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Hidenori Tanaka, Hiroh Saji, Atsushi Kawaguchi, Shinya Kimura
Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML. Cancer immunology research 6 (6) (2018)
Hiroshi Ureshino, Kana Kusaba, Keisuke Kidoguchi, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Mariko Yoshimura, Masako Yokoo, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Eisaburo Sueoka, Shinya Kimura
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma. Annals of hematology 98 (2) (2018)
Atsujiro Nishioka, Hiroshi Ureshino, Toshihiko Ando, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Hidekazu Itamura, Yasushi Kubota, Kensuke Kojima, Koichi Ohshima, Shinya Kimura
Three coexisting lymphomas in a single patient: composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma. International journal of hematology 107 (6) (2017)
Hiroshi Ureshino, Kazuharu Kamachi, Masaharu Miyahara
Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients. Annals of hematology 96 (9) (2017)
Hiroshi Ureshino, Toshihiko Ando, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Takero Shindo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura
Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma. Hematological oncology 36 (1) (2017)
Takaomi Kobayashi, Daisuke Mori, Hiroshi Ureshino, Shinichi Kido, Sonoko Ikeda, Shinya Kimura, Alan Kawarai Lefor, Eijo Matsuishi
Primary effusion lymphoma-like lymphoma with a T cell phenotype. Annals of hematology 97 (4) (2017)
Hiroshi Ureshino, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Shinya Kimura
5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10). International journal of hematology 105 (5) (2016)